E-LIB Suche - Ergebnisse für: Bogus, Ashley

1

Perioperative cefazolin prescribing rates following suppres..:

Bogus, Ashley ; McGinnis, Kelley ; Vergin, Joshua...
Infection Control & Hospital Epidemiology. , 2024

2

Perioperative cefazolin prescribing rates following suppres..:

Bogus, Ashley ; McGinnis, Kelley ; May, Sara...
Antimicrobial Stewardship & Healthcare Epidemiology. 3 (2023) S2 - p. s98-s99 , 2023

Link: https://doi.org/10.1017/..

3

Perioperative cefazolin prescribing rates following suppres..:

Ashley Bogus ; Kelley McGinnis ; Sara May...
https://www.cambridge.org/core/product/identifier/S2732494X23003698/type/journal_article. , 2023

Link: https://doi.org/10.1017/..

4

A phase 2 multiple ascending dose study of the inhaled pan-..:

Singh, Dave ; Bogus, Maxim ; Moskalenko, Valentyn...
European Respiratory Journal. 58 (2021) 4 - p. 2100673 , 2021

Link: https://doi.org/10.1183/..

5

A phase 2 multiple ascending dose study of the inhaled pan-..:

Singh, Dave ; Bogus, Maxim ; Moskalenko, Valentyn...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859971/. , 2021

Link: http://www.ncbi.nlm.nih...

6

A phase 2 multiple ascending dose study of the inhaled pan-..:

Singh, Dave ; Bogus, Maxim ; Moskalenko, Valentyn...
Singh , D , Bogus , M , Moskalenko , V , Lord , R , Moran , E J , Crater , G D , Bourdet , D L , Pfeifer , N D , Woo , J , Kaufman , E , Lombardi , D A , Weng , E Y , Nguyen , T , Woodcock , A , Haumann , B & Saggar , R 2021 , ' A phase 2 multiple ascending dose study of the inhaled pan-JAK inhibitor nezulcitinib (TD-0903) in severe COVID-19 ' , European Respiratory Journal , vol. 58 , no. 4 , 2100673 . https://doi.org/10.1183/13993003.00673-2021. , 2021

Link: https://research.manches..